OCT-2008: FOR IMMEDIATE RELEASE 

Unigen Life Sciences Ltd. announced that it has received approvals from the Thailand Food and Drug Administration (TFDA) for 5 new generic anabolic steroids – 3 injectables and 2 orals since January 2008. 

Unigen Life Sciences specializes in WHO GMP hormone manufacturing and has been operating since 2002 and has registered offices throughout south east asia. 

THAILAND FDA APPROVED PHARMACEUTICALS:  

INJECTABLES 

• TEST COMP 250 – Sustanon-like Blend of 4 Testosterone Esters – Thai FDA #2C 3/51 – Approved 18/JAN/2008
• DEPO TEST 250 – Testosterone Enanthate injectable as 250mg/mL in multidose vial - Thai FDA #1C 29/51 -Approved 06/Feb/2008
• NANDRO 250 – Nandrolone Decanoate injectable as 250mg/mL in multidose vial – Thai FDA # 1C 107/51 – Approved 16/May/2008 

ORALS 

• STANZTAB 10 – Stanozolol Oral tablets 10mg per tablet – Thai FDA # 1C 137/51 – Approved 19/Jun/2008
• MESVIRON 25 – Mesterolone Oral tablets 25mg per tablet  – Thai FDA # 1C 199/51 – Approved 10/Oct/2008

All Unigen Life Sciences Ltd. products are protected by our internet activation and authentication platform which enables secure scratch-off PIN number to serial number matching using custom-die multi-layer holograms that are taper resistant.  Matching holograms with serial number imprints are used to seal the edges of all packaging.  Activations cannot be duplicated. 

Media inquiries email to press@unigen-lifesciences.com